MIST · Milestone Pharmaceuticals Inc.
$1.15
-0.03 (-2.14%)
At close · Aug 5
Market Cap
$142.55M
Shares
124.50M
Milestone Pharmaceuticals Inc. Earnings Call Transcripts
Every quarterly earnings call for Milestone Pharmaceuticals Inc. (MIST) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q4
2026-05-13
Milestone Pharmaceuticals Inc. Q4 FY2025 Earnings Call
Confident tone
FDA approval and launch of Cardamist
Prescriber and patient adoption
Payer access and reimbursement strategy
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q1
2026-05-13
Milestone Pharmaceuticals Inc. Q1 FY2026 Earnings Call
Confident tone
Cardamist commercial launch
Payer coverage and formulary access
AFib RVR Phase 3 development
Revenue
$238,000
Diluted EPS
$-0.20
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-03
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q2
2024-08-08
Milestone Pharmaceuticals Inc. Q2 FY2024 Earnings Call
Diluted EPS
$-0.14
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-13
Milestone Pharmaceuticals Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.35
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1408443
CUSIP
59935V107
13F (30d)
19 filings
19 filers
Visit website
Investor relations